Title : Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan.

Pub. Date : 2022

PMID : 35345577






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Association of AGTR1 A1166C and CYP2C9*3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan. Valsartan cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 The present study aimed to investigate whether the antihypertensive effect of the ARB drug valsartan was associated with angiotensin II type 1 receptor (AGTR1) gene polymorphism (A1166 C) and cytochrome P450 enzyme 2C9 (CYP2C9) gene polymorphism (CYP2C9*3). Valsartan cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 The present study aimed to investigate whether the antihypertensive effect of the ARB drug valsartan was associated with angiotensin II type 1 receptor (AGTR1) gene polymorphism (A1166 C) and cytochrome P450 enzyme 2C9 (CYP2C9) gene polymorphism (CYP2C9*3). Valsartan cytochrome P450 family 2 subfamily C member 9 Homo sapiens
4 The present study aimed to investigate whether the antihypertensive effect of the ARB drug valsartan was associated with angiotensin II type 1 receptor (AGTR1) gene polymorphism (A1166 C) and cytochrome P450 enzyme 2C9 (CYP2C9) gene polymorphism (CYP2C9*3). Valsartan cytochrome P450 family 2 subfamily C member 9 Homo sapiens